Keros Therapeutics

Keros Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematological and musculoskeletal disorders. They make money through the development and potential commercialization of their proprietary therapeutic candidates, which target key pathways involved in the regulation of red blood cell production and muscle growth. Founded in 2015, Keros has made significant strides in advancing its pipeline, including its lead product candidate, KER-050, aimed at treating anemia and other blood disorders.

Recent Posts by Keros Therapeutics

1-20 of 90